The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up

Cancer

Volumn 103, Issue 12, 2005, Pages 2481-2484

  Sanders, Melinda E ^a   Schuyler, Peggy A ^a   Dupont, William D ^a   Page, David L ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Ductal carcinoma in situ; Long term follow up; Low grade; Natural history

Indexed keywords

ADULT; ARTICLE; BREAST CARCINOMA; BREAST DUCT; CANCER GRADING; CARCINOMA IN SITU; CLINICAL ARTICLE; DUCTAL CARCINOMA IN SITU; FEMALE; HUMAN; INVASIVE CARCINOMA; METASTASIS; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR BIOPSY;

ADULT; BIOPSY; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 20444379234     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21069     Document Type: Article

References (14)

1. Page DL, Dupont WD, Rogers LW, Landenberger M. Intraductal carcinoma of the breast: follow-up after biopsy only. Cancer. 1982;49:751-758.
2. Page DL, Dupont WD, Rogers LW, Jensen RA, Schuyler PA. Continued local recurrence of carcinoma 15-25 years after a diagnosis of ductal carcinoma in situ of the breast treated only by biopsy. Cancer. 1995;76:1197-1200.
3. Page DL, Dupont WD, Rogers LW, Rados MS. Atypical hyperplastic lesions of the female breast: a long term follow up study. Cancer. 1985;55:2698-2708.
4. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985; 312:146-151.
5. Laigios MD, Margloin FR, Wesdahl PR, Rose MR. Mammographically detected duct carcinoma in situ. Cancer. 1989; 63:618-624.
6. Schwartz GF, Finkel GC, Garcia JC, Patchefsky AS. Subclinical carcinoma in situ: treatment by local excision and surveillance alone. Cancer. 1992;70:2468-2474.
7. Bellamy COC, McDonald C, Salter DM, Chetty U, Anderson TJ. Noninvasive ductal carcinoma of the breast: the relevance of histologie characterization. Hum Pathol. 1993;24:16-23.
8. Betsill WL, Rosen PP, Lieberman PH, Robbins GF. Intraductal carcinoma: long-term follow-up after treatment by biopsy alone. JAMA. 1978;239:1863-1867.
9. Page DL, Rogers LW. Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia. Hum Pathol. 1992;23:1095-1097.
10. Page DL, Jensen RJ. Ductal carcinoma in situ: pathology-its role in guiding therapy. In: Singletary SE, Robb GL, Hortobagyi GN, editors. Advanced therapy of breast disease, 2nd edition. Hamilton, ON: BC Decker Inc., 2004:281-288.
11. Rosen PP, Braun DW, Kinne DE. The clinical significance of pre-invasive breast carcinoma. Cancer. 1980;46:919-925.
12. Silverstein MJ, Lagios MD, Groshen S, et al. The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med. 1999;340:1455-1461.
13. Fischer ER, Dignam J, Tan-Chiu E, et al. Pathologic findings from the NSABP eight year update of protocol B-17. Cancer. 1999;86:429-438.
14. Bijker N, Peterse JL, Duchateau L, et al. Risk factors for recurrence and metastasis after breast conserving therapy for ductal carcinoma in situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol. 2001;19:2263-2271.